AA
CALA

ALPS Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

ALPS Advisors’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,604
Closed -$621K – 904
2019
Q1 		$621K Buy
4,604
+198
+4% +$20.8K ﹤0.01% 448
2018
Q4 		$353K Buy
4,406
+1,222
+38% +$121K ﹤0.01% 705
2018
Q3 		$334K Buy
3,184
+583
+22% +$55.5K ﹤0.01% 889
2018
Q2 		$260K Buy
2,601
+222
+9% +$25.2K ﹤0.01% 892
2018
Q1 		$300K Buy
2,379
+413
+21% +$64.4K ﹤0.01% 817
2017
Q4 		$328K Buy
+1,966
New +$503K ﹤0.01% 721

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ALPS Advisors's CALA Position: Q2 2019 in Review

ALPS Advisors sold out of Calithera Biosciences, Inc (CALA) in Q2 2019, closing a stake of 4,604 shares — an estimated $621K sold.

ALPS Advisors first reported a position in CALA in Q4 2017 and held it in 6 quarters. The position peaked at $621K in Q1 2019. 92 funds tracked by Wall St. Rank hold CALA as of Q2 2019.

  • ALPS Advisors reported no remaining Calithera Biosciences, Inc position as of Q2 2019 after selling out during the quarter.
  • ALPS Advisors sold 4,604 Calithera Biosciences, Inc shares in Q2 2019, an estimated $621K.
  • ALPS Advisors first reported a position in Calithera Biosciences, Inc in Q4 2017 and held it in 6 quarters.
  • ALPS Advisors's Calithera Biosciences, Inc position peaked at $621K in Q1 2019.
  • 92 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2019.

Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.